Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Ringed Structures of the HD 163296 Protoplanetary Disk Revealed by ALMA.

Isella A, Guidi G, Testi L, Liu S, Li H, Li S, Weaver E, Boehler Y, Carperter JM, De Gregorio-Monsalvo I, Manara CF, Natta A, Pérez LM, Ricci L, Sargent A, Tazzari M, Turner N.

Phys Rev Lett. 2016 Dec 16;117(25):251101. doi: 10.1103/PhysRevLett.117.251101. Epub 2016 Dec 12.

PMID:
28036197
2.

Targeting Immune Regulatory Networks to Counteract Immune Suppression in Cancer.

Camisaschi C, Vallacchi V, Vergani E, Tazzari M, Ferro S, Tuccitto A, Kuchuk O, Shahaj E, Sulsenti R, Castelli C, Rodolfo M, Rivoltini L, Huber V.

Vaccines (Basel). 2016 Nov 4;4(4). pii: E38. Review.

3.

Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib Treatment.

Tazzari M, Indio V, Vergani B, De Cecco L, Rini F, Negri T, Camisaschi C, Fiore M, Stacchiotti S, Dagrada GP, Casali PG, Gronchi A, Astolfi A, Pantaleo MA, Villa A, Lombardo C, Arienti F, Pilotti S, Rivoltini L, Castelli C.

J Invest Dermatol. 2017 Feb;137(2):484-493. doi: 10.1016/j.jid.2016.06.634. Epub 2016 Sep 5.

4.

Spiral density waves in a young protoplanetary disk.

Pérez LM, Carpenter JM, Andrews SM, Ricci L, Isella A, Linz H, Sargent AI, Wilner DJ, Henning T, Deller AT, Chandler CJ, Dullemond CP, Lazio J, Menten KM, Corder SA, Storm S, Testi L, Tazzari M, Kwon W, Calvet N, Greaves JS, Harris RJ, Mundy LG.

Science. 2016 Sep 30;353(6307):1519-1521.

PMID:
27708098
5.

Sunitinib-induced morpho-functional changes and drug effectiveness in malignant solitary fibrous tumours.

Spagnuolo RD, Brich S, Bozzi F, Conca E, Castelli C, Tazzari M, Maestro R, Brenca M, Gualeni AV, Gloghini A, Stacchiotti S, Pierotti MA, Pilotti S, Negri T.

Oncotarget. 2016 Jul 19;7(29):45015-45026. doi: 10.18632/oncotarget.7523.

6.

Immunomodulatory Factors Control the Fate of Melanoma Tumor Initiating Cells.

Tuccitto A, Tazzari M, Beretta V, Rini F, Miranda C, Greco A, Santinami M, Patuzzo R, Vergani B, Villa A, Manenti G, Cleris L, Giardiello D, Alison M, Rivoltini L, Castelli C, Perego M.

Stem Cells. 2016 Oct;34(10):2449-2460. doi: 10.1002/stem.2413. Epub 2016 Jun 28.

7.

Evolution of Dermatofibrosarcoma Protuberans to DFSP-Derived Fibrosarcoma: An Event Marked by Epithelial-Mesenchymal Transition-like Process and 22q Loss.

Stacchiotti S, Astolfi A, Gronchi A, Fontana A, Pantaleo MA, Negri T, Brenca M, Tazzari M, Urbini M, Indio V, Colombo C, Radaelli S, Brich S, Dei Tos AP, Casali PG, Castelli C, Dagrada GP, Pilotti S, Maestro R.

Mol Cancer Res. 2016 Sep;14(9):820-9. doi: 10.1158/1541-7786.MCR-16-0068. Epub 2016 Jun 2.

8.

Efficacy and Biological Activity of Imatinib in Metastatic Dermatofibrosarcoma Protuberans (DFSP).

Stacchiotti S, Pantaleo MA, Negri T, Astolfi A, Tazzari M, Dagrada GP, Urbini M, Indio V, Maestro R, Gronchi A, Fiore M, Dei Tos AP, Conca E, Palassini E, Vincenzi B, Grosso F, Pilotti S, Castelli C, Casali PG.

Clin Cancer Res. 2016 Feb 15;22(4):837-46. doi: 10.1158/1078-0432.CCR-15-1243. Epub 2015 Aug 10.

9.

Melan-A/MART-1 immunity in a EWS-ATF1 translocated clear cell sarcoma patient treated with sunitinib: a case report.

Tazzari M, Palassini E, Vergani B, Villa A, Rini F, Negri T, Colombo C, Crippa F, Morosi C, Casali PG, Pilotti S, Stacchiotti S, Rivoltini L, Castelli C.

BMC Cancer. 2015 Feb 14;15:58. doi: 10.1186/s12885-015-1044-0.

10.

Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy.

Tazzari M, Negri T, Rini F, Vergani B, Huber V, Villa A, Dagrada P, Colombo C, Fiore M, Gronchi A, Stacchiotti S, Casali PG, Pilotti S, Rivoltini L, Castelli C.

Br J Cancer. 2014 Sep 23;111(7):1350-62. doi: 10.1038/bjc.2014.437. Epub 2014 Aug 7.

11.

Modulation of the myeloid compartment of the immune system by angiogenic- and kinase inhibitor-targeted anti-cancer therapies.

Castelli C, Rivoltini L, Rodolfo M, Tazzari M, Belgiovine C, Allavena P.

Cancer Immunol Immunother. 2015 Jan;64(1):83-9. doi: 10.1007/s00262-014-1576-1. Epub 2014 Jul 4. Review.

PMID:
24993564
12.

Activity of sunitinib in extraskeletal myxoid chondrosarcoma.

Stacchiotti S, Pantaleo MA, Astolfi A, Dagrada GP, Negri T, Dei Tos AP, Indio V, Morosi C, Gronchi A, Colombo C, Conca E, Toffolatti L, Tazzari M, Crippa F, Maestro R, Pilotti S, Casali PG.

Eur J Cancer. 2014 Jun;50(9):1657-64. doi: 10.1016/j.ejca.2014.03.013. Epub 2014 Apr 2.

PMID:
24703573
13.

Monitoring the frequency and function of regulatory T cells and summary of the approaches currently used to inhibit regulatory T cells in cancer patients.

Camisaschi C, Tazzari M, Rivoltini L, Castelli C.

Methods Mol Biol. 2014;1139:201-21. doi: 10.1007/978-1-4939-0345-0_18.

PMID:
24619682
14.

Structured myeloid cells and anti-angiogenic therapy in alveolar soft part sarcoma.

Castelli C, Tazzari M, Negri T, Vergani B, Rivoltini L, Stacchiotti S, Pilotti S.

J Transl Med. 2013 Sep 27;11:237. doi: 10.1186/1479-5876-11-237.

15.

Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.

Camisaschi C, Filipazzi P, Tazzari M, Casati C, Beretta V, Pilla L, Patuzzo R, Maurichi A, Cova A, Maio M, Chiarion-Sileni V, Tragni G, Santinami M, Vergani B, Villa A, Berti E, Umansky L, Beckhove P, Umansky V, Parmiani G, Rivoltini L, Castelli C.

Cancer Immunol Immunother. 2013 May;62(5):897-908. doi: 10.1007/s00262-013-1397-7. Epub 2013 Apr 16.

16.

Intradermal DNA electroporation induces survivin-specific CTLs, suppresses angiogenesis and confers protection against mouse melanoma.

Lladser A, Ljungberg K, Tufvesson H, Tazzari M, Roos AK, Quest AF, Kiessling R.

Cancer Immunol Immunother. 2010 Jan;59(1):81-92. doi: 10.1007/s00262-009-0725-4. Epub 2009 Jun 14.

PMID:
19526360

Supplemental Content

Loading ...
Support Center